Nicolas Williet
0000-0002-7296-5464
12 papers found
Refreshing results…
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN)
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma
The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn’s Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Effect of Endocuff-assisted colonoscopy on adenoma detection rate: meta-analysis of randomized controlled trials
Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker
Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literature
Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients
Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease
Missing publications? Search for publications with a matching author name.